Anti-sclerostin antibodies for the treatment of osteoporosis

To assess the benefits and harms of anti-sclerostin antibodies for the treatment of osteoporosis.

This is a protocol.

Health topics:

Rheumatology > Osteoporosis > Pharmacological therapies

Published:

21 April 2017

Authors:

Pundole X, Lopez-Olivo M, Suarez-Almazor ME, Lu H

Was this helpful? Donate.

If you found this evidence helpful, please consider donating to Cochrane. We are a charity that produces accessible evidence to help people make health and care decisions.
Donate
Print
PDF
Citation
Pundole X, Lopez-Olivo M, Suarez-Almazor ME, Lu H. Anti-sclerostin antibodies for the treatment of osteoporosis. Cochrane Database of Systematic Reviews 2017, Issue 4. Art. No.: CD012640. DOI: 10.1002/14651858.CD012640